Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: TUI, Oxford Biomedica board members linked to buys

(Sharecast News) - TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.

The travel giant said Sebastian Ebel picked up 49,900 shares on 26 September in a single transaction outside a trading venue.

Ebel paid €4.99 for each share, valuing the transaction at a total of €224,325.21 (£194,816.35).

Elsewhere, Oxford Biomedica disclosed a purchase linked to one of its non-executive directors.

The company said Sandra Juliet Ferera Hayden bought 12,000 shares on 26 September in a single transaction on the London Stock Exchange.

Hayden paid 293.5p for each share, valuing the purchase at £35,220.00.

In its disclosure, Oxford Biomedica said Sandra Hayden is a person closely associated with non-executive director Michael Hayden.

At 1304 BST, shares in TUI were up 3.39% in London at 451.6p, while those in Oxford Biomedica were 1.72% weaker at 286.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Director dealings: CVS Group's Scott Morrison snaps up shares
(Sharecast News) - CVS Group revealed on Thursday that group general counsel Scott Morrison had acquired 987 ordinary shares in the FTSE 250-listed veterinary services business.
Director dealings: Convatec CEO snaps up shares
(Sharecast News) - Convatec revealed on Wednesday that chief executive Jonny Mason had acquired 50,000 ordinary shares in the FTSE 100-listed medical products and technologies firm.
Director dealings: Experian director snaps up shares
(Sharecast News) - Experian revealed on Tuesday that non-executive director Eduardo Vassimon snapped up 5,650 ordinary shares in the FTSE 100-listed data and technology firm.
Director dealings: 3i Group CEO invests, Shell boss makes EUR 1.49m sale
(Sharecast News) - Among the director dealings disclosed to the market in London on Friday, 3i Group chief executive Simon Borrows bought shares in the investment company, while Shell chief executive Wael Sawan sold shares in the energy major.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.